Stay updated on Bemcentinib in AML/MDS Clinical Trial

Sign up to get notified when there's something new on the Bemcentinib in AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bemcentinib in AML/MDS Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page has removed a citation regarding the revised recommendations of the International Working Group for Diagnosis and Treatment Outcomes in Acute Myeloid Leukemia, which is a significant loss of core content.
    Difference
    0.7%
    Check dated 2025-05-08T14:18:25.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.4%
    Check dated 2025-05-01T06:33:56.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-04-24T02:13:58.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The webpage has undergone significant content removal, particularly regarding a Phase Ib/II study of bemcentinib (BGB324) for treating Acute Myeloid Leukemia (AML) and Myelodysplastic syndrome (MDS), including detailed study protocols and inclusion/exclusion criteria. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    28%
    Check dated 2025-04-16T21:04:15.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding a new date of December 19, 2024.
    Difference
    0.9%
    Check dated 2025-04-09T16:53:07.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new revision version (v2.14.3) and a new results posting date of March 25, 2025, replacing the previous estimated dates and version. This indicates a significant update in the content's accuracy and relevance.
    Difference
    0.6%
    Check dated 2025-04-02T01:24:49.000Z thumbnail image

Stay in the know with updates to Bemcentinib in AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bemcentinib in AML/MDS Clinical Trial page.